{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:02:20Z","timestamp":1792069340553,"version":"4.4.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neuron.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:38:51Z","timestamp":1647427131000},"page":"1304-1317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":320,"title":["ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias"],"prefix":"10.1016","volume":"110","author":[{"given":"Yuka A.","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2022.03.004_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer\u2019s disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2022.03.004_bib2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib3","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib4","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2022.03.004_bib8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A Quarter Century of APOE and Alzheimer\u2019s Disease: Progress to Date and the Path Forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0014-4886(95)90021-7","article-title":"Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer\u2019s disease","volume":"132","author":"Benzing","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib10","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuron.2022.03.004_bib12","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib13","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.1106420108","article-title":"Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions","volume":"108","author":"Chen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib14","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of Lipids in Alzheimer\u2019s Disease Pathology and Potential Therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuron.2022.03.004_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jnen\/60.4.342","article-title":"Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation","volume":"60","author":"Cho","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jmb.2003.09.059","article-title":"Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain","volume":"334","author":"Choy","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuron.2022.03.004_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-010-0666-1","article-title":"Accumulation of intraneuronal Abeta correlates with ApoE4 genotype","volume":"119","author":"Christensen","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2022.03.004_bib20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuron.2022.03.004_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000092960","article-title":"Apolipoprotein E epsilon4 allele frequency in vascular dementia","volume":"22","author":"Davidson","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuron.2022.03.004_bib23","doi-asserted-by":"crossref","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib24","doi-asserted-by":"crossref","first-page":"E634","DOI":"10.3390\/ijms18030634","article-title":"Phosphoinositides, Major Actors in Membrane Trafficking and Lipid Signaling Pathways","volume":"18","author":"De Craene","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2022.03.004_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer\u2019s Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.03.004_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.03.004_bib27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/aje\/kwab033","article-title":"Impact of the Apolipoprotein E \u03b54 Allele on the Relationship Between Healthy Lifestyle and Cognitive Decline: A Population-Based Study","volume":"190","author":"Dhana","year":"2021","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuron.2022.03.004_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","article-title":"APOE genotype and stress response - a mini review","volume":"15","author":"Dose","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib29","doi-asserted-by":"crossref","first-page":"E9521","DOI":"10.3390\/ijms21249521","article-title":"Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer\u2019s Disease","volume":"21","author":"Eysert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2022.03.004_bib30","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neuron.2022.03.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceca.2017.01.003","article-title":"The endoplasmic reticulum-mitochondria coupling in health and disease: Molecules, functions and significance","volume":"62","author":"Filadi","year":"2017","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuron.2022.03.004_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/glycob\/cwz084","article-title":"O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain","volume":"30","author":"Flowers","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.neuron.2022.03.004_bib33","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1705080114","article-title":"A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions","volume":"114","author":"Frieden","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib37","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2013.3841","article-title":"Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown","volume":"70","author":"Halliday","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuron.2022.03.004_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuron.2022.03.004_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002490100172","article-title":"The structural basis for amyloid formation by plasma apolipoproteins: a review","volume":"31","author":"Hatters","year":"2002","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.neuron.2022.03.004_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuron.2022.03.004_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","article-title":"Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils","volume":"361","author":"Hatters","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuron.2022.03.004_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.biochem.71.110601.135342","article-title":"Lipoprotein receptors in the nervous system","volume":"71","author":"Herz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuron.2022.03.004_bib45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2009","article-title":"Reelin, lipoprotein receptors and synaptic plasticity","volume":"7","author":"Herz","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-1-18","article-title":"Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons","volume":"1","author":"Hoe","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and A\u03b2 metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"Pt A","key":"10.1016\/j.neuron.2022.03.004_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib50","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1873-3468.13428","article-title":"Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation","volume":"593","author":"Hubin","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuron.2022.03.004_bib51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuron.2022.03.004_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-0854.2000.010301.x","article-title":"Lipid metabolism and regulation of membrane trafficking","volume":"1","author":"Huijbregts","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.neuron.2022.03.004_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","article-title":"Lack of hepatic apoE does not influence early A\u03b2 deposition: observations from a new APOE knock-in model","volume":"14","author":"Huynh","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jprot.2012.05.027","article-title":"Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls","volume":"76","author":"Jaros","year":"2012","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.neuron.2022.03.004_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(96)12661-6","article-title":"Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain","volume":"210","author":"Jolivalt","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuron.2022.03.004_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib57","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20180653","article-title":"Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau","volume":"215","author":"Kang","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib58","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1096\/fj.202000659R","article-title":"Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein","volume":"34","author":"Ke","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.neuron.2022.03.004_bib59","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","article-title":"Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-\u03b2 amyloidosis","volume":"31","author":"Kim","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib159","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2022.03.004_bib60","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-\u03b2","volume":"135","author":"Koffie","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2022.03.004_bib61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.21696","article-title":"Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age","volume":"65","author":"Kok","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib62","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuron.2022.03.004_bib63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","article-title":"More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration","volume":"83","author":"Lane-Donovan","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib64","doi-asserted-by":"crossref","first-page":"E6336","DOI":"10.3390\/ijms21176336","article-title":"ApoE Lipidation as a Therapeutic Target in Alzheimer\u2019s Disease","volume":"21","author":"Lanfranco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2022.03.004_bib65","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","article-title":"Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290","volume":"9","author":"Lee","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neuron.2022.03.004_bib66","doi-asserted-by":"crossref","first-page":"e0227667","DOI":"10.1371\/journal.pone.0227667","article-title":"Redefining transcriptional regulation of the APOE gene and its association with Alzheimer\u2019s disease","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2022.03.004_bib67","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1523\/JNEUROSCI.2468-15.2015","article-title":"APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration","volume":"35","author":"Levy","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib68","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","article-title":"Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation","volume":"128","author":"Liao","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2022.03.004_bib69","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.neuron.2018.06.011","article-title":"APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer\u2019s Disease Phenotypes in Human iPSC-Derived Brain Cell Types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib70","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 Accelerates Early Seeding of Amyloid Pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.neuron.2022.03.004_bib72","doi-asserted-by":"crossref","first-page":"c9375","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib73","doi-asserted-by":"crossref","first-page":"105615","DOI":"10.1016\/j.nbd.2022.105615","article-title":"APOE4 confers transcriptomic and functional alterations to primary mouse microglia","volume":"164","author":"Machlovi","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.neuron.2022.03.004_bib75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib76","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J.\u00a0Lipid Res."},{"issue":"Suppl","key":"10.1016\/j.neuron.2022.03.004_bib77","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuron.2022.03.004_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt0303-255","article-title":"Proteomic analysis of post-translational modifications","volume":"21","author":"Mann","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuron.2022.03.004_bib79","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","article-title":"Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls","volume":"127","author":"Mart\u00ednez-Morillo","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2022.03.004_bib80","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","article-title":"Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture","volume":"74","author":"Michikawa","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2022.03.004_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2004.11.005","article-title":"Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta","volume":"19","author":"Morikawa","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib84","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-019-0324-6","article-title":"Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease","volume":"14","author":"Najm","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib86","doi-asserted-by":"crossref","first-page":"108224","DOI":"10.1016\/j.celrep.2020.108224","article-title":"PICALM Rescues Endocytic Defects Caused by the Alzheimer\u2019s Disease Risk Factor APOE4","volume":"33","author":"Narayan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.03.004_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","article-title":"Endosome function and dysfunction in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"26","author":"Nixon","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2022.03.004_bib88","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib89","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fnins.2017.00702","article-title":"The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in\u00a0Vivo","volume":"11","author":"Nuriel","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuron.2022.03.004_bib91","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41467-020-20440-5","article-title":"A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids","volume":"12","author":"Park","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2022.03.004_bib92","doi-asserted-by":"crossref","first-page":"e72034","DOI":"10.7554\/eLife.72034","article-title":"NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load","volume":"10","author":"Pohlkamp","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.neuron.2022.03.004_bib93","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib94","doi-asserted-by":"crossref","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.03.004_bib95","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1021\/bi0504052","article-title":"Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD\/E site in\u00a0vitro","volume":"44","author":"Raftery","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuron.2022.03.004_bib96","doi-asserted-by":"crossref","first-page":"e202102136","DOI":"10.1083\/jcb.202102136","article-title":"Lipid droplets in the nervous system","volume":"220","author":"Ralhan","year":"2021","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuron.2022.03.004_bib97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","article-title":"APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis","volume":"85","author":"Rannikm\u00e4e","year":"2014","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuron.2022.03.004_bib99","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib100","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib101","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/bbrc.1995.1389","article-title":"Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis","volume":"208","author":"Richey","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuron.2022.03.004_bib102","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib103","first-page":"002","article-title":"Apolipoprotein E Fragmentation within Lewy Bodies of the Human Parkinson\u2019s Disease Brain","volume":"1","author":"Rohn","year":"2018","journal-title":"Int J Neurodegener Dis"},{"key":"10.1016\/j.neuron.2022.03.004_bib104","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1194\/jlr.M090043","article-title":"Mechanisms that minimize retinal impact of apolipoprotein E absence","volume":"59","author":"Saadane","year":"2018","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuron.2022.03.004_bib105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","article-title":"APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway","volume":"8","author":"Sando","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib106","doi-asserted-by":"crossref","first-page":"5716409","DOI":"10.1155\/2017\/5716409","article-title":"Protein Posttranslational Modifications: Roles in Aging and Age-Related Disease","volume":"2017","author":"Santos","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuron.2022.03.004_bib107","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2022.03.004_bib108","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0b013e31829bfda4","article-title":"APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis","volume":"81","author":"Schilling","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2022.03.004_bib109","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neurobiolaging.2012.06.020","article-title":"ApoE \u03b54 is associated with eIF2\u03b1 phosphorylation and impaired learning in young mice","volume":"34","author":"Segev","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2022.03.004_bib111","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2022.03.004_bib112","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib114","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.24628","article-title":"APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations","volume":"79","author":"Shinohara","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib113","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-016-1580-y","article-title":"Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer\u2019s disease","volume":"132","author":"Shinohara","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2022.03.004_bib115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0925-4439(99)00047-2","article-title":"Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site","volume":"1454","author":"Shuvaev","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuron.2022.03.004_bib116","doi-asserted-by":"crossref","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib117","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-190074","article-title":"The Effects of APOE4 on Mitochondrial Dynamics and Proteins in\u00a0vivo","volume":"70","author":"Simonovitch","year":"2019","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib118","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/17460441.2021.1972255","article-title":"How necessary are animal models for modern drug discovery?","volume":"16","author":"Singh","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neuron.2022.03.004_bib119","doi-asserted-by":"crossref","first-page":"eabb1717","DOI":"10.1126\/scitranslmed.abb1717","article-title":"Endosomal recycling reconciles the Alzheimer\u2019s disease paradox","volume":"12","author":"Small","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","article-title":"The identity and function of microglia in neurodegeneration","volume":"19","author":"Song","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuron.2022.03.004_bib121","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib122","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.03.004_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2017.01.014","article-title":"APOE \u03b54 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis","volume":"53","author":"Sudre","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2022.03.004_bib124","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-143102","article-title":"Genetics of vascular dementia: systematic review and meta-analysis","volume":"46","author":"Sun","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2022.03.004_bib125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuron.2022.03.004_bib126","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","article-title":"Amyloid-\u03b2 pathology and APOE genotype modulate retinoid X receptor agonist activity in\u00a0vivo","volume":"289","author":"Tai","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib127","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15252\/embr.201540614","article-title":"ApoE4 upregulates the activity of mitochondria-associated ER membranes","volume":"17","author":"Tambini","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuron.2022.03.004_bib128","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/hmg\/ddl220","article-title":"Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration","volume":"15","author":"Thakkinstian","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2022.03.004_bib129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1212\/01.WNL.0000128091.92139.0F","article-title":"Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2022.03.004_bib130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03b54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2018.08.006","article-title":"Glia-specific APOE epigenetic changes in the Alzheimer\u2019s disease brain","volume":"1698","author":"Tulloch","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2022.03.004_bib132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jprot.2015.05.038","article-title":"Analysis of differentially expressed novel post-translational modifications of plasma apolipoprotein E in Taiwanese females with breast cancer","volume":"126","author":"Uen","year":"2015","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.neuron.2022.03.004_bib133","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-8-13","article-title":"In\u00a0vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis","volume":"8","author":"Ulrich","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib134","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-019-0323-7","article-title":"Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: impact of genetic risk factors","volume":"14","author":"Van Acker","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/art.37720","article-title":"The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and \u03b2-actin","volume":"65","author":"van Beers","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuron.2022.03.004_bib137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.14212","article-title":"Endoplasmic reticulum-mitochondria crosstalk: from junction to function across neurological disorders","volume":"1457","author":"Veeresh","year":"2019","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.neuron.2022.03.004_bib138","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib139","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2022.03.004_bib140","doi-asserted-by":"crossref","first-page":"e10329","DOI":"10.1371\/journal.pone.0010329","article-title":"Abundant lipid and protein components of drusen","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2022.03.004_bib141","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.03.004_bib142","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2022.03.004_bib143","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuron.2022.03.004_bib144","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","article-title":"Association of Apolipoprotein E \u03b54 With Transactive Response DNA-Binding Protein 43","volume":"75","author":"Wennberg","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib145","doi-asserted-by":"crossref","first-page":"e38013","DOI":"10.1371\/journal.pone.0038013","article-title":"In\u00a0vivo human apolipoprotein E isoform fractional turnover rates in the CNS","volume":"7","author":"Wildsmith","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2022.03.004_bib146","doi-asserted-by":"crossref","first-page":"e40048","DOI":"10.7554\/eLife.40048","article-title":"Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease","volume":"7","author":"Xian","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.neuron.2022.03.004_bib147","doi-asserted-by":"crossref","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib148","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.03.004_bib149","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","article-title":"Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study","volume":"17","author":"Yang","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuron.2022.03.004_bib151","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1515\/bmc-2014-0039","article-title":"Epigenetic considerations of the APOE gene. [corrected]","volume":"6","author":"Yu","year":"2015","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.neuron.2022.03.004_bib153","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1074\/jbc.M113.526095","article-title":"Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor\/retinoic acid receptor pathway","volume":"289","author":"Zhao","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.03.004_bib154","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.03.004_bib155","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE \u03b52 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2022.03.004_bib156","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2022.03.004_bib157","doi-asserted-by":"crossref","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.03.004_bib158","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.1510011112","article-title":"Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer\u2019s disease pathogenesis","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662732200229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662732200229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:36:08Z","timestamp":1760254568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089662732200229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":159,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S089662732200229X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}